Arteriosclerosis Obliterans
📧 Sign up to get email alerts when something new happens for Arteriosclerosis Obliterans.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans
A clinical trial investigating outcomes and improvements of different treatments for arteriosclerosis obliterans; the study is currently rec…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
A follow-up gene therapy trial for critical limb ischemia is currently enrolling by invitation, sponsored by Beijing Northland Biotech Co., …
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker [Phase 4]
Phase 4 trial evaluating the effects of cilostazol and probucol on atherosclerosis-related biomarkers in Type 2 Diabetes Mellitus and Arteri…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Combined Treatment for Non-Healing Wounds in Chronic Lower Extremity Arterial Disease: a Comparative Study [NA]
A clinical trial update describes an ongoing comparative study of combined treatment for non-healing wounds in chronic lower extremity arter…
-
CLINICAL_TRIALS research · 2017-03-10Clinical Trial Update: A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of alprostadil liposomes for injection to treat lower extremity arterioscle…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages
A completed clinical trial examining preoperative heart rate variability and baroreflex sensitivity in patients with Arteriosclerosis Oblite…